The company specializes in nanoparticle technologies for innovative therapeutic approaches to treat ophthalmic diseases and conditions, with a focus on developing a proprietary therapy for patients with retinal degenerative conditions, such as Retinitis Pigmentosa. However, the technology could also have positive benefits in other conditions like Macular Degeneration, Glaucoma, and Diabetic Retinopathy. 2C Tech's ocular medical devices are designed to provide effective and meaningful therapeutic benefits to patients with retinal degenerative conditions, leveraging their expertise in nanoparticle and Quantum Dot technologies.